A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions
Serious renal involvement in systemic diseases is common and generally constitutes a pivotal prognostic factor, making those pathology frequently seen in nephrology departments. Authors describe the case of a nine-year-old girl with lupus nephritis. After admission the patient’s state deteriorated o...
Gespeichert in:
Veröffentlicht in: | Pediatric nephrology (Berlin, West) West), 2020-05, Vol.35 (5), p.777-779 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 779 |
---|---|
container_issue | 5 |
container_start_page | 777 |
container_title | Pediatric nephrology (Berlin, West) |
container_volume | 35 |
creator | Gliwińska, Aleksandra Bjanid, Omar Adamczyk, Piotr Czubilińska-Łada, Justyna Dzienniak, Anna Morawiecka-Pietrzak, Małgorzata Roszkowska-Bjanid, Dagmara Morawiec-Knysak, Aurelia Szczepańska, Maria |
description | Serious renal involvement in systemic diseases is common and generally constitutes a pivotal prognostic factor, making those pathology frequently seen in nephrology departments. Authors describe the case of a nine-year-old girl with lupus nephritis. After admission the patient’s state deteriorated over a period of a few days, with an unremitting high-grade fever, significant weakness and drowsiness, generalized erythema, and decrease of the kidney function to eGFR nadir of 56 ml/min/1,73m
2
. Treatment with pulsed methylprednisolone was started. After the first pulse the general state of the patient improved slightly, although laboratory tests showed an alarming evolution, with the exacerbation of anemia, leukopenia, neutropenia, increase of serum CRP concentration, extremely high D-dimer concentration and increase in activity of lactate dehydrogenase. The concentration of ferritin rose reaching the level of 540 μg/l, triglicerydes level was also high. Intravenous cyclophosphamide pulse therapy was added to the ongoing steroid treatment, and resulted in a radical patient improvement. Authors underline that it seems important to be aware of rare, non-renal, but potentially devastating complications of systemic diseases, like in this clinical case: the secondary hemophagocytic lymphohistiocytosis (HLH). When HLH complicates a rheumatic disease, it is also referred to as macrophage activation syndrome (MAS). Unfortunately treatment of MAS is still based on reports provided by individual centres and gathered own experiences so drawing up unambiguous diagnostic criteria will be valuable in future. The treatment should be individually tailored, and more specific evidence-based recommendations are needed. |
doi_str_mv | 10.1007/s00467-019-04411-7 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7096360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A618594818</galeid><sourcerecordid>A618594818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-c0c18780685bc8fb93ae8ba6e8e2f8a59588701915c47307c979e9e77e339ae13</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhoModq3-AS8kIIg3qclkZpJ4UViKX1AQUaF3IZs9M5uSSdZkRth_b6Zb264skouQnOd9c3LOQeglo2eMUvEuU1q3glCmCK1rxoh4hBas5hVhSl49RguqOCshdnWCnuV8TSmVjWyfohPOZMVLYIG-L3EyCbCNw9Y7a0YXA44dzrs8wuAs9tN2yhjSbtzAYMaYy8kFbLAiOzCJRL_GvUv-Pf42QZ7l-Tl60hmf4cXtfop-fvzw4-Izufz66cvF8pLYltGRWGqZFJK2sllZ2a0UNyBXpgUJVSdNoxopRfkca2wtOBVWCQUKhADOlQHGT9H53nc7rQZYWwhjMl5vkxtM2ulonD6MBLfRffytBVUtb2kxeHtrkOKvOXs9uGzBexMgTllXvKoVVZVUBX39D3odpxTK9wolK8Wbpq7uqd540C50sbxrZ1O9bJlsVC2ZLBQ5QvUQoCQZA3SuXB_wZ0f4stZzh44K3jwQbMD4cZOjn266cwhWe9CmmHOC7q54jOp5xvR-xnRpg76ZMS2K6NXDst9J_g5VAfgeyCUUekj3tfqP7R8FV9nl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2382935542</pqid></control><display><type>article</type><title>A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions</title><source>SpringerLink Journals</source><creator>Gliwińska, Aleksandra ; Bjanid, Omar ; Adamczyk, Piotr ; Czubilińska-Łada, Justyna ; Dzienniak, Anna ; Morawiecka-Pietrzak, Małgorzata ; Roszkowska-Bjanid, Dagmara ; Morawiec-Knysak, Aurelia ; Szczepańska, Maria</creator><creatorcontrib>Gliwińska, Aleksandra ; Bjanid, Omar ; Adamczyk, Piotr ; Czubilińska-Łada, Justyna ; Dzienniak, Anna ; Morawiecka-Pietrzak, Małgorzata ; Roszkowska-Bjanid, Dagmara ; Morawiec-Knysak, Aurelia ; Szczepańska, Maria</creatorcontrib><description>Serious renal involvement in systemic diseases is common and generally constitutes a pivotal prognostic factor, making those pathology frequently seen in nephrology departments. Authors describe the case of a nine-year-old girl with lupus nephritis. After admission the patient’s state deteriorated over a period of a few days, with an unremitting high-grade fever, significant weakness and drowsiness, generalized erythema, and decrease of the kidney function to eGFR nadir of 56 ml/min/1,73m
2
. Treatment with pulsed methylprednisolone was started. After the first pulse the general state of the patient improved slightly, although laboratory tests showed an alarming evolution, with the exacerbation of anemia, leukopenia, neutropenia, increase of serum CRP concentration, extremely high D-dimer concentration and increase in activity of lactate dehydrogenase. The concentration of ferritin rose reaching the level of 540 μg/l, triglicerydes level was also high. Intravenous cyclophosphamide pulse therapy was added to the ongoing steroid treatment, and resulted in a radical patient improvement. Authors underline that it seems important to be aware of rare, non-renal, but potentially devastating complications of systemic diseases, like in this clinical case: the secondary hemophagocytic lymphohistiocytosis (HLH). When HLH complicates a rheumatic disease, it is also referred to as macrophage activation syndrome (MAS). Unfortunately treatment of MAS is still based on reports provided by individual centres and gathered own experiences so drawing up unambiguous diagnostic criteria will be valuable in future. The treatment should be individually tailored, and more specific evidence-based recommendations are needed.</description><identifier>ISSN: 0931-041X</identifier><identifier>EISSN: 1432-198X</identifier><identifier>DOI: 10.1007/s00467-019-04411-7</identifier><identifier>PMID: 31823041</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Case studies ; Causes of ; Cell activation ; Children ; Clinical Quiz ; Complications and side effects ; Cyclophosphamide ; Diagnosis ; Diseases ; Drowsiness ; Epidermal growth factor receptors ; Erythema ; Ferritin ; Fever ; Histiocytosis ; Intravenous administration ; L-Lactate dehydrogenase ; Lactic acid ; Leukopenia ; Lupus ; Lupus nephritis ; Lymphocytosis ; Macrophages ; Medicine ; Medicine & Public Health ; Methylprednisolone ; Nephritis ; Nephrology ; Neutropenia ; Patients ; Pediatrics ; Systemic diseases ; Systemic lupus erythematosus ; Urology</subject><ispartof>Pediatric nephrology (Berlin, West), 2020-05, Vol.35 (5), p.777-779</ispartof><rights>The Author(s) 2019</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Pediatric Nephrology is a copyright of Springer, (2019). All Rights Reserved. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-c0c18780685bc8fb93ae8ba6e8e2f8a59588701915c47307c979e9e77e339ae13</citedby><orcidid>0000-0002-6772-1983</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00467-019-04411-7$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00467-019-04411-7$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31823041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gliwińska, Aleksandra</creatorcontrib><creatorcontrib>Bjanid, Omar</creatorcontrib><creatorcontrib>Adamczyk, Piotr</creatorcontrib><creatorcontrib>Czubilińska-Łada, Justyna</creatorcontrib><creatorcontrib>Dzienniak, Anna</creatorcontrib><creatorcontrib>Morawiecka-Pietrzak, Małgorzata</creatorcontrib><creatorcontrib>Roszkowska-Bjanid, Dagmara</creatorcontrib><creatorcontrib>Morawiec-Knysak, Aurelia</creatorcontrib><creatorcontrib>Szczepańska, Maria</creatorcontrib><title>A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions</title><title>Pediatric nephrology (Berlin, West)</title><addtitle>Pediatr Nephrol</addtitle><addtitle>Pediatr Nephrol</addtitle><description>Serious renal involvement in systemic diseases is common and generally constitutes a pivotal prognostic factor, making those pathology frequently seen in nephrology departments. Authors describe the case of a nine-year-old girl with lupus nephritis. After admission the patient’s state deteriorated over a period of a few days, with an unremitting high-grade fever, significant weakness and drowsiness, generalized erythema, and decrease of the kidney function to eGFR nadir of 56 ml/min/1,73m
2
. Treatment with pulsed methylprednisolone was started. After the first pulse the general state of the patient improved slightly, although laboratory tests showed an alarming evolution, with the exacerbation of anemia, leukopenia, neutropenia, increase of serum CRP concentration, extremely high D-dimer concentration and increase in activity of lactate dehydrogenase. The concentration of ferritin rose reaching the level of 540 μg/l, triglicerydes level was also high. Intravenous cyclophosphamide pulse therapy was added to the ongoing steroid treatment, and resulted in a radical patient improvement. Authors underline that it seems important to be aware of rare, non-renal, but potentially devastating complications of systemic diseases, like in this clinical case: the secondary hemophagocytic lymphohistiocytosis (HLH). When HLH complicates a rheumatic disease, it is also referred to as macrophage activation syndrome (MAS). Unfortunately treatment of MAS is still based on reports provided by individual centres and gathered own experiences so drawing up unambiguous diagnostic criteria will be valuable in future. The treatment should be individually tailored, and more specific evidence-based recommendations are needed.</description><subject>Case studies</subject><subject>Causes of</subject><subject>Cell activation</subject><subject>Children</subject><subject>Clinical Quiz</subject><subject>Complications and side effects</subject><subject>Cyclophosphamide</subject><subject>Diagnosis</subject><subject>Diseases</subject><subject>Drowsiness</subject><subject>Epidermal growth factor receptors</subject><subject>Erythema</subject><subject>Ferritin</subject><subject>Fever</subject><subject>Histiocytosis</subject><subject>Intravenous administration</subject><subject>L-Lactate dehydrogenase</subject><subject>Lactic acid</subject><subject>Leukopenia</subject><subject>Lupus</subject><subject>Lupus nephritis</subject><subject>Lymphocytosis</subject><subject>Macrophages</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methylprednisolone</subject><subject>Nephritis</subject><subject>Nephrology</subject><subject>Neutropenia</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Systemic diseases</subject><subject>Systemic lupus erythematosus</subject><subject>Urology</subject><issn>0931-041X</issn><issn>1432-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kl1rFDEUhoModq3-AS8kIIg3qclkZpJ4UViKX1AQUaF3IZs9M5uSSdZkRth_b6Zb264skouQnOd9c3LOQeglo2eMUvEuU1q3glCmCK1rxoh4hBas5hVhSl49RguqOCshdnWCnuV8TSmVjWyfohPOZMVLYIG-L3EyCbCNw9Y7a0YXA44dzrs8wuAs9tN2yhjSbtzAYMaYy8kFbLAiOzCJRL_GvUv-Pf42QZ7l-Tl60hmf4cXtfop-fvzw4-Izufz66cvF8pLYltGRWGqZFJK2sllZ2a0UNyBXpgUJVSdNoxopRfkca2wtOBVWCQUKhADOlQHGT9H53nc7rQZYWwhjMl5vkxtM2ulonD6MBLfRffytBVUtb2kxeHtrkOKvOXs9uGzBexMgTllXvKoVVZVUBX39D3odpxTK9wolK8Wbpq7uqd540C50sbxrZ1O9bJlsVC2ZLBQ5QvUQoCQZA3SuXB_wZ0f4stZzh44K3jwQbMD4cZOjn266cwhWe9CmmHOC7q54jOp5xvR-xnRpg76ZMS2K6NXDst9J_g5VAfgeyCUUekj3tfqP7R8FV9nl</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Gliwińska, Aleksandra</creator><creator>Bjanid, Omar</creator><creator>Adamczyk, Piotr</creator><creator>Czubilińska-Łada, Justyna</creator><creator>Dzienniak, Anna</creator><creator>Morawiecka-Pietrzak, Małgorzata</creator><creator>Roszkowska-Bjanid, Dagmara</creator><creator>Morawiec-Knysak, Aurelia</creator><creator>Szczepańska, Maria</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6772-1983</orcidid></search><sort><creationdate>20200501</creationdate><title>A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions</title><author>Gliwińska, Aleksandra ; Bjanid, Omar ; Adamczyk, Piotr ; Czubilińska-Łada, Justyna ; Dzienniak, Anna ; Morawiecka-Pietrzak, Małgorzata ; Roszkowska-Bjanid, Dagmara ; Morawiec-Knysak, Aurelia ; Szczepańska, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-c0c18780685bc8fb93ae8ba6e8e2f8a59588701915c47307c979e9e77e339ae13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Case studies</topic><topic>Causes of</topic><topic>Cell activation</topic><topic>Children</topic><topic>Clinical Quiz</topic><topic>Complications and side effects</topic><topic>Cyclophosphamide</topic><topic>Diagnosis</topic><topic>Diseases</topic><topic>Drowsiness</topic><topic>Epidermal growth factor receptors</topic><topic>Erythema</topic><topic>Ferritin</topic><topic>Fever</topic><topic>Histiocytosis</topic><topic>Intravenous administration</topic><topic>L-Lactate dehydrogenase</topic><topic>Lactic acid</topic><topic>Leukopenia</topic><topic>Lupus</topic><topic>Lupus nephritis</topic><topic>Lymphocytosis</topic><topic>Macrophages</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methylprednisolone</topic><topic>Nephritis</topic><topic>Nephrology</topic><topic>Neutropenia</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Systemic diseases</topic><topic>Systemic lupus erythematosus</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gliwińska, Aleksandra</creatorcontrib><creatorcontrib>Bjanid, Omar</creatorcontrib><creatorcontrib>Adamczyk, Piotr</creatorcontrib><creatorcontrib>Czubilińska-Łada, Justyna</creatorcontrib><creatorcontrib>Dzienniak, Anna</creatorcontrib><creatorcontrib>Morawiecka-Pietrzak, Małgorzata</creatorcontrib><creatorcontrib>Roszkowska-Bjanid, Dagmara</creatorcontrib><creatorcontrib>Morawiec-Knysak, Aurelia</creatorcontrib><creatorcontrib>Szczepańska, Maria</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric nephrology (Berlin, West)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gliwińska, Aleksandra</au><au>Bjanid, Omar</au><au>Adamczyk, Piotr</au><au>Czubilińska-Łada, Justyna</au><au>Dzienniak, Anna</au><au>Morawiecka-Pietrzak, Małgorzata</au><au>Roszkowska-Bjanid, Dagmara</au><au>Morawiec-Knysak, Aurelia</au><au>Szczepańska, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions</atitle><jtitle>Pediatric nephrology (Berlin, West)</jtitle><stitle>Pediatr Nephrol</stitle><addtitle>Pediatr Nephrol</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>35</volume><issue>5</issue><spage>777</spage><epage>779</epage><pages>777-779</pages><issn>0931-041X</issn><eissn>1432-198X</eissn><abstract>Serious renal involvement in systemic diseases is common and generally constitutes a pivotal prognostic factor, making those pathology frequently seen in nephrology departments. Authors describe the case of a nine-year-old girl with lupus nephritis. After admission the patient’s state deteriorated over a period of a few days, with an unremitting high-grade fever, significant weakness and drowsiness, generalized erythema, and decrease of the kidney function to eGFR nadir of 56 ml/min/1,73m
2
. Treatment with pulsed methylprednisolone was started. After the first pulse the general state of the patient improved slightly, although laboratory tests showed an alarming evolution, with the exacerbation of anemia, leukopenia, neutropenia, increase of serum CRP concentration, extremely high D-dimer concentration and increase in activity of lactate dehydrogenase. The concentration of ferritin rose reaching the level of 540 μg/l, triglicerydes level was also high. Intravenous cyclophosphamide pulse therapy was added to the ongoing steroid treatment, and resulted in a radical patient improvement. Authors underline that it seems important to be aware of rare, non-renal, but potentially devastating complications of systemic diseases, like in this clinical case: the secondary hemophagocytic lymphohistiocytosis (HLH). When HLH complicates a rheumatic disease, it is also referred to as macrophage activation syndrome (MAS). Unfortunately treatment of MAS is still based on reports provided by individual centres and gathered own experiences so drawing up unambiguous diagnostic criteria will be valuable in future. The treatment should be individually tailored, and more specific evidence-based recommendations are needed.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31823041</pmid><doi>10.1007/s00467-019-04411-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6772-1983</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0931-041X |
ispartof | Pediatric nephrology (Berlin, West), 2020-05, Vol.35 (5), p.777-779 |
issn | 0931-041X 1432-198X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7096360 |
source | SpringerLink Journals |
subjects | Case studies Causes of Cell activation Children Clinical Quiz Complications and side effects Cyclophosphamide Diagnosis Diseases Drowsiness Epidermal growth factor receptors Erythema Ferritin Fever Histiocytosis Intravenous administration L-Lactate dehydrogenase Lactic acid Leukopenia Lupus Lupus nephritis Lymphocytosis Macrophages Medicine Medicine & Public Health Methylprednisolone Nephritis Nephrology Neutropenia Patients Pediatrics Systemic diseases Systemic lupus erythematosus Urology |
title | A rare complication of systemic lupus erythematosus in a 9-year-old girl: Questions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A12%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20rare%20complication%20of%20systemic%20lupus%20erythematosus%20in%20a%209-year-old%20girl:%20Questions&rft.jtitle=Pediatric%20nephrology%20(Berlin,%20West)&rft.au=Gliwi%C5%84ska,%20Aleksandra&rft.date=2020-05-01&rft.volume=35&rft.issue=5&rft.spage=777&rft.epage=779&rft.pages=777-779&rft.issn=0931-041X&rft.eissn=1432-198X&rft_id=info:doi/10.1007/s00467-019-04411-7&rft_dat=%3Cgale_pubme%3EA618594818%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2382935542&rft_id=info:pmid/31823041&rft_galeid=A618594818&rfr_iscdi=true |